- Home
- CLDX vs CET Comparison
CLDX vs CET Comparison
Compare CLDX & CET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLDX
- CET
- Stock Information
- Founded
- CLDX 1983
- CET 1929
- Country
- CLDX United States
- CET United States
- Employees
- CLDX N/A
- CET N/A
- Industry
- CLDX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- CET Finance/Investors Services
- Sector
- CLDX Health Care
- CET Finance
- Exchange
- CLDX Nasdaq
- CET Nasdaq
- Market Cap
- CLDX 1.6B
- CET 1.3B
- IPO Year
- CLDX 2008
- CET N/A
- Fundamental
- Price
- CLDX $23.78
- CET $46.83
- Analyst Decision
- CLDX Buy
- CET
- Analyst Count
- CLDX 7
- CET 0
- Target Price
- CLDX $64.83
- CET N/A
- AVG Volume (30 Days)
- CLDX 1.1M
- CET 34.0K
- Earning Date
- CLDX 02-24-2025
- CET 01-01-0001
- Dividend Yield
- CLDX N/A
- CET 4.93%
- EPS Growth
- CLDX N/A
- CET 64.57
- EPS
- CLDX N/A
- CET 10.32
- Revenue
- CLDX $9,976,000.00
- CET $23,374,777.00
- Revenue This Year
- CLDX N/A
- CET N/A
- Revenue Next Year
- CLDX N/A
- CET N/A
- P/E Ratio
- CLDX N/A
- CET $4.53
- Revenue Growth
- CLDX 128.55
- CET 41.71
- 52 Week Low
- CLDX $22.17
- CET $36.89
- 52 Week High
- CLDX $53.18
- CET $49.51
- Technical
- Relative Strength Index (RSI)
- CLDX 41.99
- CET 60.43
- Support Level
- CLDX $22.17
- CET $44.53
- Resistance Level
- CLDX $29.05
- CET $45.95
- Average True Range (ATR)
- CLDX 1.57
- CET 0.55
- MACD
- CLDX -0.26
- CET 0.17
- Stochastic Oscillator
- CLDX 23.40
- CET 95.84
About CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. Its pipeline products are Varlilumab, CDX-301, CDX-1140,CDX-0159/Anti-KIT Program, and CDX-527.
About CET Central Securities Corporation
Central Securities Corp is a non-diversified closed-end management investment company. Its investment objective is long-term growth of capital. The company invests in common stocks, bonds, convertible bonds, preferred stocks, convertible preferred stocks, warrants, options real estate, or short-term obligations of governments, banks, and corporations.